Evidence map›Paper›PMID 25171109›Full record

ArticleMolecular medicine (Cambridge, Mass.)2015

Reduction of cardiac cell death after helium postconditioning in rats: transcriptional analysis of cell death and survival pathways.

Gezina T M L Oei, Michal Heger, Rowan F van Golen, Lindy K Alles, Moritz Flick, Allard C van der Wal, Thomas M van Gulik, Markus W Hollmann, Benedikt Preckel, Nina C Weber

Open access · goldAbstract read
In one paragraph

Article in Molecular medicine (Cambridge, Mass.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Optimal Use of 2',7'-Dichlorofluorescein Diacetate in Cultured Hepatocytes.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Gezina T M L OeiDepartment of Anesthesiology, Laboratory of Experimental Intensive Care and Anesthesiology (L.E.I.C.A.), University of Amsterdam, Amsterdam, The Netherlands.
Michal HegerDepartment of Experimental Surgery, University of Amsterdam, Amsterdam, The Netherlands.
Rowan F van GolenDepartment of Experimental Surgery, University of Amsterdam, Amsterdam, The Netherlands.
Lindy K AllesDepartment of Experimental Surgery, University of Amsterdam, Amsterdam, The Netherlands.
Moritz FlickDepartment of Anesthesiology, Laboratory of Experimental Intensive Care and Anesthesiology (L.E.I.C.A.), University of Amsterdam, Amsterdam, The Netherlands.
Allard C van der WalDepartment of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Thomas M van GulikDepartment of Experimental Surgery, University of Amsterdam, Amsterdam, The Netherlands.
Markus W HollmannDepartment of Anesthesiology, Laboratory of Experimental Intensive Care and Anesthesiology (L.E.I.C.A.), University of Amsterdam, Amsterdam, The Netherlands.
Benedikt PreckelDepartment of Anesthesiology, Laboratory of Experimental Intensive Care and Anesthesiology (L.E.I.C.A.), University of Amsterdam, Amsterdam, The Netherlands.
Nina C WeberDepartment of Anesthesiology, Laboratory of Experimental Intensive Care and Anesthesiology (L.E.I.C.A.), University of Amsterdam, Amsterdam, The Netherlands.
Academic Medical Center · NLUniversity of Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Helium, a noble gas, has been used safely in humans. In animal models of regional myocardial ischemia/reperfusion (I/R) it was shown that helium conditioning reduces infarct size. Currently, it is not known how helium exerts its cytoprotective effects and which cell death/survival pathways are affected. The objective of this study, therefore, was to investigate the cell protective effects of helium postconditioning by PCR array analysis of genes involved in necrosis, apoptosis and autophagy. Male rats were subjected to 25 min of ischemia and 5, 15 or 30 min of reperfusion. Semiquantitative histological analysis revealed that 15 min of helium postconditioning reduced the extent of I/R-induced cell damage. This effect was not observed after 5 and 30 min of helium postconditioning. Analysis of the differential expression of genes showed that 15 min of helium postconditioning mainly caused upregulation of genes involved in autophagy and inhibition of apoptosis versus I/R alone. The results suggest that the cytoprotective effects of helium inhalation may be caused by a switch from pro-cell-death signaling to activation of cell survival mechanisms, which appears to affect a wide range of pathways.

Indexed as

Ischemic PostconditioningAnimalsCardiotonic AgentsCell DeathCell SurvivalCoronary CirculationHeliumMaleMyocardial Reperfusion InjuryMyocardiumRats, WistarRNA, MessengerTranscriptomeCardiotonic AgentsHeliumRNA, Messenger

Identifiers

PMID25171109
PMCPMC4365058
OpenAlexW2336747137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.